{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:52:57Z","timestamp":1791035577025,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009093","name":"Spanish Foundation of Hemotology and Hemotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.medcli.2026.107570","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:20:26Z","timestamp":1787372426000},"page":"107570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linfoma linfobl\u00e1stico del adulto: diagn\u00f3stico, pron\u00f3stico y tratamiento"],"prefix":"10.1016","volume":"166","author":[{"given":"Vitor","family":"Botafogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107570_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-021-01168-x","article-title":"Lymphoblastic lymphoma: a concise review","volume":"24","author":"Intermesoli","year":"2022","journal-title":"Curr Oncol Rep."},{"key":"10.1016\/j.medcli.2026.107570_bib0320","doi-asserted-by":"crossref","first-page":"101449","DOI":"10.1016\/j.beha.2023.101449","article-title":"Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults","volume":"36","author":"Temple","year":"2023","journal-title":"Best Pract Res Clin Haematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0325","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0330","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clml.2017.05.016","article-title":"Prognostic factors and outcomes of adult lymphoblastic lymphoma in the United States","volume":"17","author":"El-Fattah","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.medcli.2026.107570_bib0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exphem.2017.04.002","article-title":"Adult T-type lymphoblastic lymphoma: treatment advances and prognostic indicators","volume":"51","author":"Lepretre","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.medcli.2026.107570_bib0340","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2026.107570_bib0345","volume":"2","year":"2017"},{"key":"10.1016\/j.medcli.2026.107570_bib0350","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.modpat.2024.100466","volume":"37","author":"Choi","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.medcli.2026.107570_bib0355","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0360","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","article-title":"Lymphoblastic lymphoma","volume":"113","author":"Cortelazzo","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0365","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3389\/fonc.2019.01304","article-title":"Myeloid\/lymphoid neoplasm with FGFR1 rearrangement accompanying RUNX1 and NOTCH1 gene mutations","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0370","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/leu.2010.312","article-title":"Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European Leukemia Net Work Package 10","volume":"25","author":"B\u00e9n\u00e9","year":"2011","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2026.107570_bib0375","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2023020794","article-title":"Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0380","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/s41379-021-00853-3","article-title":"Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia","volume":"34","author":"Klairmont","year":"2021","journal-title":"Mod Pathol."},{"key":"10.1016\/j.medcli.2026.107570_bib0385","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/path.6476","article-title":"Mutation profiling in differential diagnosis between TdT-positive high-grade\/large B-cell lymphoma and B-lymphoblastic leukaemia\/lymphoma","volume":"267","author":"Tzioni","year":"2025","journal-title":"J Pathol."},{"key":"10.1016\/j.medcli.2026.107570_bib0390","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.12042","volume":"159","author":"Patel","year":"2012","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00428-025-04168-5","article-title":"Exploring the boundaries between neoplastic and reactive lymphoproliferations: lymphoid neoplasms with indolent behavior and clonal lymphoproliferations\u2014a report of the 2024 EA4HP\/SH lymphoma workshop","volume":"487","author":"Quintanilla-Mart\u00ednez","year":"2025","journal-title":"Virchows Archiv."},{"key":"10.1016\/j.medcli.2026.107570_bib0400","first-page":"205","article-title":"Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias","volume":"246","author":"Szczepa\u0144ski","year":"1999","journal-title":"Curr Top Microbiol Immunol."},{"key":"10.1016\/j.medcli.2026.107570_bib0405","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/gcc.22726","article-title":"Non-leukemic pediatric mixed phenotype acute leukemia\/lymphoma: genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma","volume":"58","author":"Martin-Guerrero","year":"2019","journal-title":"Genes Chromosomes Cancer."},{"key":"10.1016\/j.medcli.2026.107570_bib0410","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1080\/10428194.2020.1761970","article-title":"Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood","volume":"61","author":"Knez","year":"2020","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2026.107570_bib0415","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41375-022-01757-0","article-title":"Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma","volume":"37","author":"Au-Yeung","year":"2023","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2026.107570_bib0420","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1182\/bloodadvances.2020001822","article-title":"T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?","volume":"4","author":"Kroeze","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.medcli.2026.107570_bib0425","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08788.x","volume":"154","author":"Sekimizu","year":"2011","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0430","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3324\/haematol.2019.220863","article-title":"Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma","volume":"105","author":"Li","year":"2020","journal-title":"Haematologica."},{"issue":"Supplement 1","key":"10.1016\/j.medcli.2026.107570_bib0435","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2024-203827","article-title":"Genomic Biomarkers of Poor Outcome in Patients with T-Cell Lymphoblastic Lymphoma","volume":"144","author":"Newman","year":"2024","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0440","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0445","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.18632\/oncotarget.9144","article-title":"A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.medcli.2026.107570_bib0450","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0455","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/0284186X.2014.889850","article-title":"Treatment outcome in T-cell lymphoblastic lymphoma in adults \u2013 a population-based study from the Swedish Lymphoma Registry","volume":"53","author":"Ellin","year":"2014","journal-title":"Acta Oncol (Madr)."},{"key":"10.1016\/j.medcli.2026.107570_bib0460","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2404156","article-title":"High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2026.107570_bib0465","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0470","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood.2024024344","article-title":"MRD: also for T-lymphoblastic lymphoma","volume":"143","author":"Ribera","year":"2024","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0475","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2015.203","article-title":"Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia","volume":"30","author":"Balbach","year":"2016","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2026.107570_bib0480","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2020005381","article-title":"Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance","volume":"137","author":"Khanam","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0485","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0490","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1200\/JCO.2008.21.1318","volume":"27","author":"Coustan-Smith","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0495","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.20.00531","article-title":"Successful outcomes of newly diagnosed t lymphoblastic lymphoma: results from Children's Oncology Group AALL0434","volume":"38","author":"Hayashi","year":"2020","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0500","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/pbc.25607","article-title":"Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: the AIEOP experience","volume":"62","author":"Mussolin","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"10.1016\/j.medcli.2026.107570_bib0505","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.2023021184","article-title":"MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231","volume":"143","author":"Hayashi","year":"2024","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0510","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/bjh.18707","article-title":"Prognostic value of PET\/CT and CT in T-cell lymphoblastic lymphoma\/leukaemia patients: A retrospective cohort study of 145 patients","volume":"201","author":"Rouzaud","year":"2023","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0515","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/bjh.70053","article-title":"T-cell lymphoblastic lymphoma in children, adolescents and young adults","volume":"207","author":"Te Vrugt","year":"2025","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0520","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1182\/blood.V116.21.2831.2831","article-title":"Long-term outcome for de novo lymphoblastic lymphoma (LL) after frontline therapy with hyper-CVAD regimen and variants","volume":"116","author":"Thomas","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0525","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood."},{"issue":"Supplement 1","key":"10.1016\/j.medcli.2026.107570_bib0530","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood-2022-158381","article-title":"Results of the risk-adapted MRD-stratified GMALL Trial 08\/2013 in 281 T-ALL \/T-Lbl patients: excellent outcome of standard risk thymic T-ALL","volume":"140","author":"Goekbuget","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-011-1252-x","article-title":"Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma","volume":"91","author":"Cortelazzo","year":"2012","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0540","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.21.02678","volume":"40","author":"Teachey","year":"2022","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2026.107570_bib0545","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","article-title":"The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma","volume":"94","author":"Dabaja","year":"2002","journal-title":"Cancer."},{"key":"10.1016\/j.medcli.2026.107570_bib0550","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V124.21.370.370","article-title":"Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography","volume":"124","author":"G\u00f6kbuget","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0555","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","article-title":"A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma","volume":"101","author":"Levine","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0560","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1158\/1078-0432.CCR-19-4207","article-title":"A CpG methylation classifier to predict relapse in adults with T-cell lymphoblastic lymphoma","volume":"26","author":"Tian","year":"2020","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.medcli.2026.107570_bib0565","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2023023568","article-title":"Management of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0570","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00277-024-06121-z","article-title":"The efficacy and safety of nelarabine in relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"104","author":"Shakeel","year":"2025","journal-title":"Ann Hematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0575","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ajh.25957","article-title":"Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed\/refractory T-cell acute lymphoblastic leukemia\/lymphoma. A CAMPUS ALL study","volume":"95","author":"Candoni","year":"2020","journal-title":"Am J Hematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0580","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/bloodadvances.2022008280","article-title":"Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma\/leukemia","volume":"7","author":"Shimony","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.medcli.2026.107570_bib0585","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.2024024493","article-title":"Daratumumab in pediatric relapsed\/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study","volume":"144","author":"Bhatla","year":"2024","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0590","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/cam4.4478","article-title":"Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: phase 2 study","volume":"11","author":"Boissel","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.medcli.2026.107570_bib0595","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-024-02414-4","article-title":"Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma","author":"Ravandi","year":"2024","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2026.107570_bib0600","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/ajh.27094","article-title":"Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy","volume":"98","author":"Zhang","year":"2023","journal-title":"Am J Hematol."},{"issue":"Supplement 1","key":"10.1016\/j.medcli.2026.107570_bib0605","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood-2023-178723","article-title":"Phase 1\/2 dose-escalation\/dose-expansion study of anti-CD7 allogeneic CAR-T cells (WU-CART-007) in relapsed or refractory (R\/R) T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma (T-ALL\/LBL)","volume":"142","author":"Ghobadi","year":"2023","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2026.107570_bib0610","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3324\/haematol.2023.283848","article-title":"Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia","volume":"109","author":"Oh","year":"2024","journal-title":"Haematologica."},{"key":"10.1016\/j.medcli.2026.107570_bib0615","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ajh.25801","article-title":"B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement","volume":"95","author":"Kemps","year":"2020","journal-title":"Am J Hematol."},{"key":"10.1016\/j.medcli.2026.107570_bib0620","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000519033","article-title":"T-lymphoblastic leukemia\/lymphoma and thymoma: a case report and review of the literature of a rare association","volume":"145","author":"Mizrahi","year":"2022","journal-title":"Acta Haematol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326002204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326002204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:57:09Z","timestamp":1791032229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326002204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0025775326002204"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107570","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linfoma linfobl\u00e1stico del adulto: diagn\u00f3stico, pron\u00f3stico y tratamiento","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107570"}}